Security key
14070B309
CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CAPR)
CUSIP: 14070B309
Q2 2020 13F Holders as of 30 Jun 2020
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 940,377
- Total 13F value
- $4,324,870
- Share change
- +442,065
- Put/Call ratio
- 123%
- SEC-reported price per share
- $4.60
- Number of holders
- 30
- Value change
- +$2,983,542
- Number of buys
- 26
- Number of sells
- 4
- Shares outstanding
- 51,786,227
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2020
Institutions
30
Top holders
10
CAPR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2020
Previous quarter: Q1 2020
CAPRICOR THERAPEUTICS, INC. SEC filings
CAPRICOR THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 14070B309
Recent filing periods:
Ownership snapshot
Top reported holders of CAPR - CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2020
13F
Lead comparable stake: 0.52%
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 0.52%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
0.52%
RENAISSANCE TECHNOLOGIES LLC
0.2%
VANGUARD GROUP INC
0.06%
JANE STREET GROUP, LLC
0.05%
CITADEL ADVISORS LLC
0.05%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
0.52%
|
$322,000
268,630 shares
|
— | 31 Mar 2020 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.2%
|
$124,000
103,615 shares
|
— | 31 Mar 2020 |
| VANGUARD GROUP INC |
13F
Company
|
0.06%
|
$35,000
29,419 shares
|
— | 31 Mar 2020 |
| JANE STREET GROUP, LLC |
13F
Company
|
0.05%
|
$29,000
24,150 shares
|
— | 31 Mar 2020 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.05%
|
$28,000
23,879 shares
|
— | 31 Mar 2020 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.03%
|
$15,000
13,045 shares
|
— | 31 Mar 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
30
Shares
940,377
Rows available
30
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
15
Q2 2020 holders
30
Holder diff
15
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 value | Q2 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend